November is known worldwide as the official month of awareness and prevention of prostate cancer, and the November campaign promotes attention to disease risks and incentives for routine research.
According to the Ministry of Health, prostate cancer is ranked second in the ranking of the most common diseases among men, just behind skin cancer.
In addition to the surveys and recommended care, regular sleep can also help fight this type of cancer.
Melatonin, called sleep-regulating hormone, has the potential to slow down the growth of tumors. The subject acts in the control of the formation of new blood vessels from the already existing vasculature of the tumor, a process known as angiogenesis.
According to Renata Federighi, Duoflex Sleep Consultant, melatonin is naturally produced in response to lack of lighting, which is responsible for reporting the body at bedtime. "It's important that people sleep without the disturbance of light so as not to disturb their production and harm their health," he explains.
During the night, the cells must rest completely in order not to lose efficiency and suffer mutations, which may be the causes of the appearance of a cancer. "The few hours of sleep also weaken the immune system and promote inflammatory conditions, making the body more vulnerable to tumors," adds Renata.
Harvard on prostate cancer
A study conducted by Harvard University in the United States, observed that satisfactory levels of melatonin may reduce the risk of prostate cancer. They evaluated 928 men, those who presented high levels of the hormone, the likelihood of developing the disease that was shown to be 75% lower.
The specialist advises on a quality sleep and for proper repair of the body's functions. "It's important to pay attention to the posture, use a pillow that offers comfort and support for the head and adjusts the spine, keeps the environment cool and as quiet and dark as possible, eat healthy and avoid stimulating activities before sleep," concludes Duoflex Dream Consultant.